{"id":"W2121098984","doi":"10.1126/scitranslmed.aac9511","title":"Plasma <i>AR</i> and abiraterone-resistant prostate cancer","year":2015,"lang":"en","type":"article","venue":"Science Translational Medicine","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":441,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Institute of Cancer Research; Prostate Cancer UK; National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Abiraterone; Prostate cancer; Medicine; Cancer; Abiraterone acetate; Prostate; Oncology; Internal medicine; Urology; Androgen deprivation therapy; Androgen receptor","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06533960079360934,"score_gpt":0.36954620893229,"score_spread":0.3042066081386806,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}